Insider Selling: Omada Health (NASDAQ:OMDA) CAO Sells $120,093.48 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 6,894 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $17.42, for a total value of $120,093.48. Following the transaction, the chief accounting officer directly owned 9,191 shares of the company’s stock, valued at $160,107.22. The trade was a 42.86% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Omada Health Price Performance

Shares of NASDAQ:OMDA opened at $17.64 on Friday. The business’s 50 day moving average price is $15.73 and its 200-day moving average price is $14.78. The firm has a market capitalization of $1.05 billion and a PE ratio of -65.33. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million during the quarter. As a group, analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. BMO Capital Markets reduced their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Wall Street Zen cut shares of Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Friday, May 8th. Finally, Wells Fargo & Company raised their target price on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Trading of Omada Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. BIT Capital GmbH purchased a new position in Omada Health during the third quarter worth about $13,639,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Omada Health in the 4th quarter valued at about $1,222,000. Divisadero Street Capital Management LP purchased a new stake in shares of Omada Health in the 3rd quarter valued at approximately $30,510,000. a16z Perennial Management L.P. purchased a new stake in shares of Omada Health in the 4th quarter valued at approximately $2,480,000. Finally, Madryn Asset Management LP acquired a new stake in shares of Omada Health during the 4th quarter worth approximately $9,212,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.